In short. An autoimmune condition in which melanocytes are lost: what is actually happening in the skin, and what vitiligo is not.
Key points
- Vitiligo behaves differently in every person.
- Some people have a few patches that never change, others spread steadily, and many have long quiet periods interrupted by activity.
- No one can predict which course yours will take, and a clinician who claims otherwise is guessing.
Vitiligo is an acquired condition in which patches of skin lose their pigment completely, leaving sharply demarcated, chalk-white or milky areas. The colour is gone rather than merely faint, and the boundary between affected and unaffected skin is usually crisp. It happens because the immune system turns on melanocytes, the cells that manufacture pigment, and destroys them. Once those cells are lost from an area, the skin there cannot make melanin at all.
It affects people of every skin colour and every ethnic background, and it is neither rare nor a sign of poor hygiene. Because the contrast is greatest in darker skin, vitiligo is often most visible there, and the visible difference can carry a heavy social weight.
What it is not
Vitiligo is not infectious and cannot be passed to anyone else by touch, by sharing food, or by any other contact. It is not caused by diet, by a particular food, by stress alone, or by anything the person did or failed to do. It is not a form of skin cancer, and the patches themselves are neither contagious nor dangerous.
It is also not simply a cosmetic problem. Vitiligo is an autoimmune condition, and people who have it are more likely than average to develop certain other autoimmune conditions, most often thyroid disease. That is a reason for sensible screening, not for alarm.
What is actually happening
The current understanding is that vitiligo arises when a genetic tendency combines with a trigger, and the immune system begins to recognise melanocytes as targets worth attacking. Why it starts in one person and not another is not fully understood. What is clear is that the process can be active or quiet: in active disease new patches appear and existing ones enlarge, while in stable disease the patches stay as they are for long periods.
Melanocytes are not always destroyed beyond recovery. In many patches some survive in the hair follicles, and those surviving cells are the reason treatment can sometimes bring pigment back. It is also why pigment returns in a speckled, follicular pattern rather than evenly, and why areas with no hair follicles, such as the lips and the fingertips, respond poorly.
An unpredictable condition
Vitiligo behaves differently in every person. Some people have a few patches that never change, others spread steadily, and many have long quiet periods interrupted by activity. No one can predict which course yours will take, and a clinician who claims otherwise is guessing.
Seek an assessment if
- New white patches are appearing, or existing patches are enlarging.
- The loss of pigment affects the eyelids, the eyes, or the skin around them.
- You have fatigue, weight change, or feel unusually cold, which may suggest a thyroid problem.
Frequently asked questions
Can vitiligo be passed to another person?
No. Vitiligo is not infectious and cannot be passed on by touch, by sharing food, or by any other contact. It is also not caused by diet, by a particular food, by stress alone, or by anything the person did or failed to do.
Why does repigmentation appear in speckles rather than as an even sheet of colour?
Treatment works from melanocytes that survived in the hair follicles. Those cells divide and spread outward, so pigment returns in a speckled, follicular pattern. Areas without hair follicles, such as the lips and the fingertips, have no such reservoir and respond poorly.
Does a diagnosis of vitiligo mean I should be checked for other conditions?
Vitiligo is an autoimmune condition, and people who have it are more likely than average to develop certain other autoimmune conditions, most often thyroid disease. That is a reason for sensible screening rather than alarm, not a sign that something else is already wrong.
Risks & Limitations
- Repigmentation is slow, measured in months to years, and is often partial rather than complete.
- Vitiligo is unpredictable: treatment can control it, but nothing guarantees that it will stop spreading.
- Treatment usually needs to continue to hold the result, and relapse is common after it is stopped.
- Prolonged topical steroid use can thin the skin, cause visible blood vessels and stretch marks, and trigger outbreaks of small spots around the hair follicles.
- Phototherapy can burn, and the ultraviolet dose accumulates over a lifetime, raising the risk of skin ageing and skin cancer.
- The face and neck respond best; the hands, feet and lips are the hardest areas, where pigment may never return.
- No treatment works for everyone, and the response of an individual patch cannot be predicted with certainty.
When to Seek Care
- Depigmentation is spreading rapidly, or new patches are appearing over weeks rather than months.
- Depigmentation involves the eyelids or the skin around the eyes.
- New symptoms suggest a thyroid or other autoimmune condition — persistent fatigue, weight change, feeling cold, a neck swelling, or excessive thirst.
- Blistering, burning or severe pain after a phototherapy session — stop treatment and seek advice.
- Eye pain, redness, light sensitivity or blurred vision, which need prompt assessment.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance on vitiligo
- Vitiligo Research Foundation — patient and clinician information resources
- Cochrane Library — systematic reviews of vitiligo treatment
- Chinese Medical Association, Dermatology Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.